A new metabolic signature contributes to disease progression and predicts worse survival in melanoma

Metabolic reprogramming is a common hallmark of tumor cells and is a crucial mediator of resistance toward anticancer therapies. The pattern of a metabolism-related signature in melanoma remains unknown. Here, we explored the role of a multi-metabolism-related gene signature in melanoma.We used the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Mengdi, Zhuang, Binyu, Dai, Xiao, Zhang, Liang, Zhao, Fangqing, You, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291831/
https://www.ncbi.nlm.nih.gov/pubmed/33084485
http://dx.doi.org/10.1080/21655979.2020.1822714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291831/
https://www.ncbi.nlm.nih.gov/pubmed/33084485
http://dx.doi.org/10.1080/21655979.2020.1822714

Ejemplares similares